Micronor and Lexapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micronor (norethindrone) and Lexapro (escitalopram oxalate). Common drug interactions include acne among females.

The phase IV clinical study analyzes what interactions people have when they take Micronor and Lexapro. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Micronor?

Micronor has active ingredients of norethindrone. It is often used in birth control. eHealthMe is studying from 1,344 Micronor users. Check the latest studies of Micronor.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

24 people who take Micronor and Lexapro together, and have interactions are studied.

Micronor and Lexapro drug interactions.

What are the common drug interactions of Micronor and Lexapro, by gender? *:

female:

  1. Acne (skin problems that cause pimples)
  2. Cardiac arrest
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Death
  7. Hypokalaemia (low potassium)
  8. Nausea (feeling of having an urge to vomit)
  9. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  10. Abnormal dreams

male:

n/a

What are the common drug interactions of Micronor and Lexapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Vomiting
  2. Dizziness
  3. Headache (pain in head)
  4. Hypokalaemia (low potassium)
  5. Nausea (feeling of having an urge to vomit)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)

30-39:

  1. Acne (skin problems that cause pimples)
  2. Cardiac arrest
  3. Coma (state of unconsciousness lasting more than six hours)
  4. Constipation
  5. Drug abuse
  6. Drug abuser
  7. Peripheral swelling
  8. Weight increased
  9. Death
  10. Dehydration (dryness resulting from the removal of water)

40-49:

  1. Abnormal dreams
  2. Depressed level of consciousness
  3. Fatigue (feeling of tiredness)
  4. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  5. Screaming (a long loud piercing cry)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Headache (pain in head)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

50-59:

  1. Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)
  2. Embolic stroke (stroke due to obstruction due to an embolus)
  3. Endometrial cancer
  4. Hypotension (abnormally low blood pressure)
  5. Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal)
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 37.50%
  2. Sleep Disorder: 3 people, 12.50%
  3. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 3 people, 12.50%
  4. Joint Pain: 3 people, 12.50%
  5. Stress And Anxiety: 2 people, 8.33%
  6. Psoriasis (immune-mediated disease that affects the skin): 2 people, 8.33%
  7. Pain: 2 people, 8.33%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.33%
  9. High Blood Pressure: 2 people, 8.33%
  10. Headache (pain in head): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Micronor and Lexapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micronor and Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micronor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micronor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on norethindrone and escitalopram oxalate (the active ingredients of Micronor and Lexapro, respectively), and Micronor and Lexapro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: